false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - The Car ...
Anchoring Holistic CKM Care Around Kidney Health
Anchoring Holistic CKM Care Around Kidney Health
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Professor Nisha Bansal explains how kidney health can anchor holistic cardiovascular-kidney-metabolic (CKM) care. CKM describes the interconnected effects of cardiovascular, kidney, and metabolic disease, shaped also by social and environmental factors. The kidney is both an outcome of CKM and an amplifier of risk, influencing blood pressure, fluid balance, metabolism, inflammation, and hormonal regulation.<br /><br />Bansal reviews the CKM staging framework, emphasizing that kidney disease enters at stage 2, advanced CKD at stage 3, and clinical cardiovascular disease at stage 4. She notes that CKM conditions are extremely common and often overlap, especially kidney and metabolic disease. Routine assessment should include kidney function and albuminuria, glucose, lipids, blood pressure, and BMI; advanced cardiovascular tests may help in high-risk patients.<br /><br />She highlights tailored care for children, older adults, people with non-metabolic kidney disease, transplant recipients, and dialysis patients. Key therapies include renin-angiotensin system inhibitors, SGLT2 inhibitors, incretin-based therapies, and aldosterone blockade. Discussion underscores transplant-specific coordination, emerging dialysis evidence, mineral-bone considerations, and albuminuria’s association with heart failure.
Asset Caption
Nisha Bansal, MD, FASN
Meta Tag
Speaker
Nisha Bansal
Keywords
kidney health
cardiovascular-kidney-metabolic
albuminuria
CKM staging
SGLT2 inhibitors
heart failure
×
Please select your language
1
English